<p dir="ltr">This project aims to develop a pioneering dance movement therapy (DMT) pilot programme tailored for individuals with mild cognitive impairment (MCI) in Aotearoa, New Zealand. Recognising the urgent need for non-pharmacological interventions to support cognitive health and reduce dementia risk, this research explores the potential of DMT to enhance holistic well-being in this population. The project adopts a staged, mixed-methods approach to investigate the effectiveness and relevance of DMT within the local context. The initial phase involves qualitative inquiry through semi-structured interviews with three key stakeholder groups: dance movement therapists, healthcare practitioners, and caregivers of individuals with MCI. These focus groups aim to generate in-depth insights into perceptions, experiences, and recommendations related to DMT as a therapeutic tool. Data from this stage will be analysed using thematic analysis to identify core themes and inform the design of a culturally responsive DMT pilot programme. Building on these findings, the second phase will involve the implementation of a two-arm randomised controlled trial to evaluate the pilot programme’s impact on cognitive functioning, emotional well-being, and quality of life. The second phase will provide preliminary evidence on the feasibility, acceptability, and potential benefits of DMT for people with MCI. Data collection for the initial phase is currently underway. Ultimately, this project seeks to bridge gaps in dementia prevention strategies by integrating creative arts therapies into early intervention frameworks, contributing to local healthcare innovation and the global discourse on dementia care.</p>